Literature DB >> 26212896

The Use of Ketamine for the Treatment of Depression in the Context of Psychotic Symptoms: To the Editor.

Carolina Medeiros da Frota Ribeiro1, Gerard Sanacora2, Ralph Hoffman2, Robert Ostroff3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26212896     DOI： 10.1016/j.biopsych.2015.05.016

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  5 in total

1.  Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion.

Authors:  Steven J Pennybaker; David A Luckenbaugh; Lawrence T Park; Craig A Marquardt; Carlos A Zarate
Journal:  Biol Psychiatry       Date:  2017-01-22       Impact factor: 13.382

2.  Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital.

Authors:  Samuel T Wilkinson; Rachel B Katz; Mesut Toprak; Ryan Webler; Robert B Ostroff; Gerard Sanacora
Journal:  J Clin Psychiatry       Date:  2018-07-24       Impact factor: 4.384

Review 3.  Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression.

Authors:  Ioline D Henter; Rafael T de Sousa; Philip W Gold; Andre R Brunoni; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Expert Rev Clin Pharmacol       Date:  2017-01-16       Impact factor: 5.045

Review 4.  Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress.

Authors:  Michael D Kritzer; Nicholas A Mischel; Jonathan R Young; Christopher S Lai; Prakash S Masand; Steven T Szabo; Sanjay J Mathew
Journal:  Ann Clin Psychiatry       Date:  2022-02       Impact factor: 2.691

Review 5.  Advantages of ketamine in pediatric anesthesia.

Authors:  Alessandro Simonini; Etrusca Brogi; Marco Cascella; Alessandro Vittori
Journal:  Open Med (Wars)       Date:  2022-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.